|
ORC3L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.969100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.817600E-03 |
| Normal-vs-Stage2 |
6.641700E-02 |
| Normal-vs-Stage3 |
1.662030E-02 |
| Normal-vs-Stage4 |
8.890300E-02 |
| Stage1-vs-Stage2 |
3.808600E-01 |
| Stage1-vs-Stage3 |
1.992780E-01 |
| Stage1-vs-Stage4 |
3.262800E-01 |
| Stage2-vs-Stage3 |
9.658000E-01 |
| Stage2-vs-Stage4 |
9.659000E-01 |
| Stage3-vs-Stage4 |
9.293200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.037400E-04 |
| Normal-vs-AfricanAmerican |
8.084500E-03 |
| Normal-vs-Asian |
9.807200E-01 |
| Caucasian-vs-AfricanAmerican |
7.072000E-01 |
| Caucasian-vs-Asian |
3.300600E-01 |
| AfricanAmerican-vs-Asian |
3.226400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.715600E-03 |
| Normal-vs-Female |
4.645800E-04 |
| Male-vs-Female |
5.293700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.121710E-02 |
| Normal-vs-Extreme_Weight |
5.048300E-02 |
| Normal-vs-Obese |
5.399000E-03 |
| Normal-vs-Extreme_Obese |
3.242200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.809620E-01 |
| Normal_Weight-vs-Obese |
5.955400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.854000E-01 |
| Extreme_Weight-vs-Obese |
2.648200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.003000E-01 |
| Obese-vs-Extreme_Obese |
8.620200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.837900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.32599999999894E-05 |
| Normal-vs-Age(61-80Yrs) |
3.687900E-02 |
| Normal-vs-Age(81-100Yrs) |
9.920200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.264000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.596440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.057820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.397600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.272100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.723000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.437470E-04 |
| Normal-VS-Type2 PRCC |
2.339800E-01 |
| Normal-VS-KIRP CIMP |
5.815900E-02 |
| Normal-VS-Unclassified PRCC |
3.421400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.776100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.579800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.342760E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.166200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.407800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.473600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.005630E-01 |
| Normal-vs-N1 |
3.384700E-04 |
| Normal-vs-N2 |
7.536000E-01 |
| N0-vs-N1 |
2.940100E-02 |
| N0-vs-N2 |
9.839600E-01 |
| N1-vs-N2 |
3.148400E-01 |
|
|
